Evidence map›Paper›PMID 36226158›Full record

ArticleOxidative medicine and cellular longevity2021

Integrated Multiomics Analysis Identifies a Novel Biomarker Associated with Prognosis in Intracerebral Hemorrhage.

Yiqing Shen, Wensong Yang, Xin Xiong, Xinhui Li, Zhongsong Xiao, Jialun Yu, Fangyu Liu, Siwen Gui, Xiongfei Xie, Fajin Lv and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Yiqing ShenDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Wensong YangDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.ORCID https://orcid.org/0000-0003-3703-4565
Xin XiongDepartment of Neurology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400011, China.
Xinhui LiDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Zhongsong XiaoDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Jialun YuDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Fangyu LiuDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Siwen GuiNHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Xiongfei XieDepartment of Radiology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China.
Fajin LvDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Libo ZhaoDepartment of Neurology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China.
Liangbo HuDepartment of Radiology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, China.
Anatol ManaenkoDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.ORCID https://orcid.org/0000-0002-6153-6226
Peng XieDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.ORCID https://orcid.org/0000-0002-4738-393X
Qi LiDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.ORCID https://orcid.org/0000-0002-9144-148X
The Affiliated Yongchuan Hospital of Chongqing Medical University · CNChongqing Medical University · CNFirst People's Hospital of Chongqing · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing treatments for intracerebral hemorrhage (ICH) are unable to satisfactorily prevent development of secondary brain injury after ICH and multiple pathological mechanisms are involved in the development of the injury. In this study, we aimed to identify novel genes and proteins and integrated their molecular alternations to reveal key network modules involved in ICH pathology. A total of 30 C57BL/6 male mice were used for this study. The collagenase model of ICH was employed, 3 days after ICH animals were tested neurological. After it, animals were euthanized and perihematomal brain tissues were collected for transcriptome and TMT labeling-based quantitative proteome analyses. Protein-protein interaction (PPI) network, Gene Set Enrichment Analysis (GSEA), and regularized Canonical Correlation Analysis (rCCA) were performed to integrated multiomics data. For validation of hub genes and proteins, qRT-PCR and Western blot were carried out. The candidate biomarkers were further measured by ELISA in the plasma of ICH patients and the controls. A total of 2218 differentially expressed genes (DEGs) and 353 differentially expressed proteins (DEPs) between the ICH model group and control group were identified. GSEA revealed that immune-related gene sets were prominently upregulated and significantly enriched in pathways of inflammasome complex, negative regulation of interleukin-12 production, and pyroptosis during the ICH process. The rCCA network presented two highly connective clusters which were involved in the sphingolipid catabolic process and inflammatory response. Among ten hub genes screened out by integrative analysis, significantly upregulated Itgb2, Serpina3n, and Ctss were validated in the ICH group by qRT-PCR and Western blot. Plasma levels of human SERPINA3 (homologue of murine Serpina3n) were elevated in ICH patients compared with the healthy controls (SERPINA3: 13.3 ng/mL vs. 11.2 ng/mL,

Indexed as

Brain InjuriesProteomeAnimalsBiomarkersCerebral HemorrhageCollagenasesHumansInflammasomesInterleukin-12MaleMiceMice, Inbred C57BLPrognosisSphingolipidsBiomarkersCollagenasesInflammasomesInterleukin-12ProteomeSphingolipids

Identifiers

PMID36226158
PMCPMC8691985
OpenAlexW4200307179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.